The management of lower urinary tract symptoms (LUTS) related to prostates over 80 cc is currently debated between proponents of laser enucleation, laser photovaporization and open simple prostatectomy especially for elderly men with comorbidities. Currently, there is a lack of long-term outcomes for laser surgery. Our goal was to evaluate the long-term functional outcomes and reoperation rate of laser photovaporization in this population.METHODS: We included consecutively all men treated for benign prostatic hypertrophy >80cc by Greenlight laser between January 2007 and December 2013 in an expert single-center. The functionnal outcomes were assessed on: Post-void residual volume (PVR), maximum flow rate (Qmax), International Prostate Symptom Score (IPSS), and Urinary Quality of Life score (Qol). All this outcomes were evaluated pre and postoperatively and every year thereafter. Data were analyzed at the date of the latest news for patients who were followed for 5 years at least. For these men we assessed the need for any reoperation or any drugs used for benign prostatic obstruction (BPO).RESULTS: 132 men were included with a median age of 72 years. There was no significant difference between postoperative and long-term functional outcomes: Qmax (16.2 ml/s vs. 15.5 ml/s, p [ 0.27), PVR (26ml vs. 36 ml, p [ 0.74) and IPSS (6.5 vs. 6.4, p [ 0.92). Only the average Qol was different with 1.2 vs. 1.6, p <0.001. Among our population, 23 men (17%) underwent at least one reoperation (mean delay of 35 months) for adenomatous regrowth: 9 PVP (7%), 9 transurethral resection of the prostate (7%), 2 open simple prostatectomy (2%) and only 3 patients had an indwelling catheter (2%). Likewise, 25% of the patients had a new prescription for LUTS.CONCLUSIONS: PVP laser is a valid alternative for prostates over 80cc in the long-term for elderly men. Our study has shown that less than one in five men will require reoperation on the urinary system for adenomatous regrowth and that the failure rate of photovaporization remains low even for large prostates. Nevertheless, patients need to be informed that BPO symptoms could reappear with the need of medications in one quarter of the cases.
Objective: Flexible cystoscopy for ureteral stent removal after ureteroscopy is widely performed. In this scenario, the real need for antimicrobial prophylaxis is still uncertain. Aim of this study is to determine the urinary tract infections rate after 4 weeks from outpatient flexible cystoscopies for ureteral stent removal without antimicrobial prophylaxis. Patients and methods: A prospective observational study was performed between November 2017 and August 2018 in a single, high-volume Institution. Risk factors for UTIs were recorded. Immediately before cystoscopy, each patient submitted a voided urine specimen. Antibiotics were not given before or after cystoscopy. About 7 and 28 days after cystoscopy all the patients underwent abdomen US, urine analysis and culture, and clinical evaluation to assess possible symptoms of UTI. Results: A total of 192 patients were enrolled in the study, 76 patients (39.2%) were female. Median age was 55 years [IQR 47- 68]. Median BMI was 24.2 [22.9-26.7]. Eighteen patients (9.4%) had asymptomatic bacteriuria before cystoscopy and 39 (20.3%) had positive culture at 7 days. About 21 patients (10.9%) were diagnosed with febrile UTI in the 28 days FU period. The 28.6 % of the Febrile patients had asymptomatic bacteriuria before the stent removal ( p < 0.001), this group was slightly older ( p = 0.085) and with higher BMI ( p = 0.036). Forty-eight patients had positive urine culture at 7 days, of whom 27 (14.1%) were asymptomatic and were classified as asymptomatic bacteriuria. Multivariate analysis shows that only high BMI and bacteriuria before the procedure were significantly associated with developing a febrile UTI, none of the other risk factors was significant. Conclusion: Our data show a high rate of UTI after flexible cystoscopies for ureteral stent removal without antimicrobial prophylaxis especially in patients with asymptomatic bacteriuria, in those with high BMI and in the elderly; in these subgroups, antimicrobial prophylaxis should be recommended.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.